Please login to the form below

Not currently logged in
Email:
Password:

reimbursement

This page shows the latest reimbursement news and features for those working in and with pharma, biotech and healthcare.

Diurnal files adrenal insufficiency drug Alkindi in US

Diurnal files adrenal insufficiency drug Alkindi in US

It has since been backed by the Scottish Medicines Consortium (SMC) for reimbursement on the NHS.

Latest news

More from news
Approximately 40 fully matching, plus 498 partially matching documents found.

Latest Intelligence

  • Assessing the risks in annuity pricing models Assessing the risks in annuity pricing models

    Three others (ChondroCelect, PROVENGE and Glybera) were withdrawn, partly due to challenges associated with reimbursement. ... Manufacturers will need to restructure traditional business and revenue forecasting models or develop entirely new models based

  • Creating value from value-based healthcare Creating value from value-based healthcare

    It may mean working with external stakeholders to move away from process-driven reimbursement and process-driven healthcare provision. ... Have a co-creation mentality with external stakeholders to move away from process-driven reimbursement and

  • Leading AstraZeneca’s return to growth in Europe Leading AstraZeneca’s return to growth in Europe

    Europe is complex when it comes to access and reimbursement. How we work with payers now and in the future will be a critical factor in how we bring innovative medicines ... Like many of its peers, AstraZeneca now firmly believes in what Reic calls

  • Gene therapy market access Q&A Gene therapy market access Q&A

    Historically, there’s been a fair amount of reluctance to adopt novel payment mechanisms like outcomes-based reimbursement schemes, often because of concerns around the administrative burden of implementing them (combined ... There’s a lesson in that,

  • Bluebird: on a mission to ‘recode’ the DNA of healthcare Bluebird: on a mission to ‘recode’ the DNA of healthcare

    All this points to a revolution brought about by cell and gene therapy, not just in clinical care, but also in the pricing and reimbursement framework to support it. ... This ‘recoding’ of pricing and reimbursement deals with payers is essential for

More from intelligence
Approximately 12 fully matching, plus 140 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 21 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 55 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
JPA Health Communications

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

Five key trends in precision and personalised healthcare
Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies...
OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...
Language barriers: Obesity has become a loaded word
...

Infographics